Literature DB >> 25845880

Commensal streptococci serve as a reservoir for β-lactam resistance genes in Streptococcus pneumoniae.

Anders Jensen1, Oskar Valdórsson2, Niels Frimodt-Møller3, Susan Hollingshead4, Mogens Kilian2.   

Abstract

Streptococcus pneumoniae is a leading cause of pneumonia, meningitis, septicemia, and middle ear infections. The incidence of S. pneumoniae isolates that are not susceptible to penicillin has risen worldwide and may be above 20% in some countries. Beta-lactam antibiotic resistance in pneumococci is associated with significant sequence polymorphism in penicillin-binding proteins (PBPs). Commensal streptococci, especially S. mitis and S. oralis, have been identified as putative donors of mutated gene fragments. However, no studies have compared sequences of the involved pbp genes in large collections of commensal streptococci with those of S. pneumoniae. We therefore investigated the sequence diversity of the transpeptidase region of the three pbp genes, pbp2x, pbp2b, and pbp1a in 107, 96, and 88 susceptible and nonsusceptible strains of commensal streptococci, respectively, at the nucleotide and amino acid levels to determine to what extent homologous recombination between commensal streptococci and S. pneumoniae plays a role in the development of beta-lactam resistance in S. pneumoniae. In contrast to pneumococci, extensive sequence variation in the transpeptidase region of pbp2x, pbp2b, and pbp1a was observed in both susceptible and nonsusceptible strains of commensal streptococci, conceivably reflecting the genetic diversity of the many evolutionary lineages of commensal streptococci combined with the recombination events occurring with intra- and interspecies homologues. Our data support the notion that resistance to beta-lactam antibiotics in pneumococci is due to sequences acquired from commensal Mitis group streptococci, especially S. mitis. However, several amino acid alterations previously linked to beta-lactam resistance in pneumococci appear to represent species signatures of the donor strain rather than being causal of resistance.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25845880      PMCID: PMC4432199          DOI: 10.1128/AAC.00429-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  52 in total

1.  Alterations in PBP 1A essential-for high-level penicillin resistance in Streptococcus pneumoniae.

Authors:  A M Smith; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

2.  Alterations in penicillin-binding protein 2B from penicillin-resistant wild-type strains of Streptococcus pneumoniae.

Authors:  A M Smith; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

3.  Inhibition of the expression of penicillin resistance in Streptococcus pneumoniae by inactivation of cell wall muropeptide branching genes.

Authors:  S R Filipe; A Tomasz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

4.  Streptococcus mitis with unusually high level resistance to beta-lactam antibiotics.

Authors:  A König; R R Reinert; R Hakenbeck
Journal:  Microb Drug Resist       Date:  1998       Impact factor: 3.431

5.  A global gene pool for high-level cephalosporin resistance in commensal Streptococcus species and Streptococcus pneumoniae.

Authors:  P Reichmann; A König; J Liñares; F Alcaide; F C Tenover; L McDougal; S Swidsinski; R Hakenbeck
Journal:  J Infect Dis       Date:  1997-10       Impact factor: 5.226

6.  Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer.

Authors:  J Carratalá; F Alcaide; A Fernández-Sevilla; X Corbella; J Lińares; F Gudiol
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

7.  Interspecies recombinational events during the evolution of altered PBP 2x genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae.

Authors:  G Laible; B G Spratt; R Hakenbeck
Journal:  Mol Microbiol       Date:  1991-08       Impact factor: 3.501

8.  Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States.

Authors:  G V Doern; M J Ferraro; A B Brueggemann; K L Ruoff
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

9.  Mosaic pbpX genes of major clones of penicillin-resistant Streptococcus pneumoniae have evolved from pbpX genes of a penicillin-sensitive Streptococcus oralis.

Authors:  C Sibold; J Henrichsen; A König; C Martin; L Chalkley; R Hakenbeck
Journal:  Mol Microbiol       Date:  1994-06       Impact factor: 3.501

10.  Evolution of penicillin resistance in Streptococcus pneumoniae; the role of Streptococcus mitis in the formation of a low affinity PBP2B in S. pneumoniae.

Authors:  C G Dowson; T J Coffey; C Kell; R A Whiley
Journal:  Mol Microbiol       Date:  1993-08       Impact factor: 3.501

View more
  26 in total

Review 1.  Stress responses in Streptococcus species and their effects on the host.

Authors:  Cuong Thach Nguyen; Sang-Sang Park; Dong-Kwon Rhee
Journal:  J Microbiol       Date:  2015-10-28       Impact factor: 3.422

2.  Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis/oralis in an Ex Vivo Simulated Endocarditis Vegetation Model.

Authors:  Razieh Kebriaei; Seth A Rice; Kyle C Stamper; Ravin Seepersaud; Cristina Garcia-de-la-Maria; Nagendra N Mishra; Jose M Miro; Cesar A Arias; Truc T Tran; Paul M Sullam; Arnold S Bayer; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

3.  Comparative genomics of invasive Streptococcus pneumoniae CC320/271 serotype 19F/19A before the introduction of pneumococcal vaccine in India.

Authors:  Rosemol Varghese; Ayyanraj Neeravi; Jobin John Jacob; Karthick Vasudevan; Jones Lionel Kumar; Nithya Subramanian; Balaji Veeraraghavan
Journal:  Mol Biol Rep       Date:  2021-04-19       Impact factor: 2.316

4.  Remodeling of Cross-bridges Controls Peptidoglycan Cross-linking Levels in Bacterial Cell Walls.

Authors:  Alexis J Apostolos; Sean E Pidgeon; Marcos M Pires
Journal:  ACS Chem Biol       Date:  2020-04-03       Impact factor: 5.100

5.  A Dual-Replicon Shuttle Vector System for Heterologous Gene Expression in a Broad Range of Gram-Positive and Gram-Negative Bacteria.

Authors:  Mingxi Hua; Jingjing Guo; Min Li; Chen Chen; Yuanyuan Zhang; Chuan Song; Dong Jiang; Pengcheng Du; Hui Zeng
Journal:  Curr Microbiol       Date:  2018-07-09       Impact factor: 2.188

6.  Amoxicillin-resistant Streptococcus pneumoniae can be resensitized by targeting the mevalonate pathway as indicated by sCRilecs-seq.

Authors:  Liselot Dewachter; Julien Dénéréaz; Xue Liu; Vincent de Bakker; Charlotte Costa; Mara Baldry; Jean-Claude Sirard; Jan-Willem Veening
Journal:  Elife       Date:  2022-06-24       Impact factor: 8.713

7.  A Quorum Sensing-Regulated Protein Binds Cell Wall Components and Enhances Lysozyme Resistance in Streptococcus pyogenes.

Authors:  Artemis Gogos; Juan Cristobal Jimenez; Jennifer C Chang; Reid V Wilkening; Michael J Federle
Journal:  J Bacteriol       Date:  2018-05-09       Impact factor: 3.490

Review 8.  β-Lactam Resistance Mechanisms: Gram-Positive Bacteria and Mycobacterium tuberculosis.

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Cold Spring Harb Perspect Med       Date:  2016-05-02       Impact factor: 6.915

9.  Streptococcus gordonii pheromone s.g.cAM373 may influence the reservoir of antibiotic resistance determinants of Enterococcus faecalis origin in the oral metagenome.

Authors:  Jillian M Mansfield; Paul Herrmann; Amy M Jesionowski; M Margaret Vickerman
Journal:  J Med Microbiol       Date:  2017-10-12       Impact factor: 2.472

10.  Pneumococci Can Become Virulent by Acquiring a New Capsule From Oral Streptococci.

Authors:  Moon H Nahm; Terry Brissac; Mogens Kilian; Jiri Vlach; Carlos J Orihuela; Jamil S Saad; Feroze Ganaie
Journal:  J Infect Dis       Date:  2020-07-06       Impact factor: 7.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.